Is a complete KTTA research report available?

No complete published report is available for Pasithea Therapeutics Corp. (KTTA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Pasithea Therapeutics Corp. (KTTA)

NASDAQ: KTTA · USD

$0.44

-0.01 (-1.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first KTTA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	14.8M
Net income (ttm)	-19.7M
EPS (ttm)	-$1.57
Shares out	33.4M
Volume	572,203
Beta	0.29

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -19.7M
EPS (ttm): -$1.57
Market cap: 14.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All KTTA indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001841330
Company name	Pasithea Therapeutics Corp.
Country	United States
Country code	US
Cusip	70261F202
Employees	5
Employees Change	1%
Employees Change Percent	25
Enterprise value	$-35.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-09-15
Isin	US70261F2020
Last refreshed	2026-07-31
Market cap	$14.8M
Market cap category	Nano-Cap
Price	$0.44
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	KTTA
Website	https://www.pasithea.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-132.12%
FCF yield	-113.44%
P/B ratio	0.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-19.7M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-3.9M
ROA	-31.49
Roa5y	-24.82
ROCE	-40.2
ROE	-58.22
Roe5y	-42.33
ROIC	-32.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-39.16%
Cagr3y	-66.67%
EPS Growth Quarters	6
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$56.4M
Cash	$50.4M
Current Assets	$52.7M
Current Liabilities	$1.5M
Debt	$0
Equity	$54.8M
Liabilities	$1.5M
Long Term Assets	$3.6M
Long Term Liabilities	$52,966
Net Cash	$50.4M
Net Cash By Market Cap	$337
Net Cash Growth	843.6%
Net Debt Equity	$-0.92
Tangible Book Value	$51.2M
Tangible Book Value Per Share	$2.05
WACC	5.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	35.4
Net Working Capital	$841,594
Quick ratio	33.84
Working Capital	$51.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-804.92%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-39.14%
200-day SMA	0.77
3Y total return	-96.3%
50-day SMA	0.56
50-day SMA vs 200-day SMA	50under200
All Time High	170
All Time High Change	-99.74%
All Time High Date	2021-11-23
All Time Low	0.28
All Time Low Change	58.01%
All Time Low Date	2025-11-21
ATR	0.04
Beta	0.29
Beta1y	11.17
Beta2y	3.97
Ch YTD	-65.58
High	0.46
High52	2.06
High52 Date	2025-11-28
High52ch	-78.45%
Low	0.43
Low52	0.28
Low52 Date	2025-11-21
Low52ch	58.01%
Ma50ch	-20.04%
Premarket Change Percent	-4.44
Premarket Price	$0.43
Premarket Volume	1,880
Price vs 200-day SMA	-42.22%
RSI	33.9
RSI Monthly	28.12
RSI Weekly	34.56
Sharpe ratio	0.22x
Sortino ratio	0.6
Total Return	-804.92%
Tr YTD	-65.58
Tr1m	-15.61%
Tr1w	-7.54%
Tr3m	-35.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.16
Operating Income	$-17.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,623,993%
Float Percent	49.75%
Net Borrowing	179,310
Shares Insiders	1.11%
Shares Institutions	14.96%
Shares Out	33,414,448
Shares Qo Q	90.58%
Shares Yo Y	804.92%
Short Float	1.46%
Short Ratio	0.15
Short Shares	0.73

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-17.3M
Adjusted OCF	-17,281,044
Average Volume	356,637.45x
Bv Per Share	2.2
Ch1m	-15.61
Ch1w	-7.54
Ch1y	-39.14
Ch3m	-35.53
Ch3y	-96.3
Ch6m	-48.37
Change	-1.33%
Change From Open	-1.33
Close	0.45
Days Gap	0
Depreciation Amortization	657,764
Dollar Volume	254,058.1
Earnings Date	2026-08-14
EBIT	$-22.1M
EBITDA	$-21.4M
EPS	$-1.57
F Score	2
FCF	$-16.9M
FCF EV Yield	47.77x
FCF Per Share	$-0.51
Financing CF	62,045,244
Fiscal Year End	December
Founded	2,020
Investing CF	11,000
Ipr	-91.06
Iprfo	-99.44
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2024-01-02
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	0.74
Ma150ch	-39.9%
Ma20	0.48
Ma20ch	-7.19%
Net CF	45,160,189
Next Earnings Date	2026-08-13
Open	0.45
Optionable	No
Position In Range	61.13
Post Close	0.44
Postmarket Change Percent	-1.98
Postmarket Price	$0.44
Pre Close	0.45
Price Date	2026-07-30
Ptbv Ratio	0.29
Relative Volume	1.6x
Share Based Comp	338,091
Tr6m	-48.37%
Us State	Florida
Volume	572,203

Pasithea Therapeutics Corp. (KTTA)

Coverage state: Market snapshot only — no published research

Generate the first KTTA analysis

Price

Financial snapshot

Fair-value bridge

Latest news · KTTA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KTTA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on KTTA

Frequently asked questions